Intra-Cellular Therapies is a pharmaceutical company established based on the groundbreaking research of the late Paul Greengard, a Nobel Prize laureate, which unveiled the impact of treatments on the internal functions of cells within the human body. Our goal is to harness this intracellular approach to provide treatments that will have a profound impact on individuals dealing with intricate psychiatric and neurologic conditions. We champion scientific advancement, embrace inquisitiveness, foster collaboration, and uphold principles of integrity and respect in everything we pursue, develop, and deliver.
Intra-Cellular Therapies
Headquarters
United States of America